[Established combinations of inhaled corticoids and long-acting beta 2-symphathomimetics for long-term therapy of bronchial asthma. Position of an expert panel study]

Pneumologie. 1999 Apr;53(4):210-2.

[Article in German]

Authors

R Buhl¹, P Kardos, H Magnussen, H Matthys, R Sauer, P Schauer, C Vogelmeier, R Wettengel, H Worth, G Menz

Affiliation

¹ III. Med. Klinik und Poliklinik Universitätsklinikum Mainz. R.Buhl@3-med.klinik.uni-mainz.de

PMID: 10409864

No abstract available

Publication types

Review

MeSH terms

Administration, Inhalation
Adrenal Cortex Hormones / administration & dosage*
Adrenal Cortex Hormones / adverse effects
Adrenergic beta-Agonists / administration & dosage*
Adrenergic beta-Agonists / adverse effects
Albuterol / administration & dosage
Albuterol / adverse effects
Albuterol / analogs & derivatives
Androstadienes / administration & dosage
Androstadienes / adverse effects
Anti-Asthmatic Agents / administration & dosage
Anti-Asthmatic Agents / adverse effects
Anti-Inflammatory Agents / administration & dosage*
Anti-Inflammatory Agents / adverse effects
Asthma / drug therapy*
Delayed-Action Preparations
Dose-Response Relationship, Drug
Drug Combinations
Fluticasone
Humans
Salmeterol Xinafoate

Substances

Adrenal Cortex Hormones
Adrenergic beta-Agonists
Androstadienes
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Delayed-Action Preparations
Drug Combinations
Salmeterol Xinafoate
Fluticasone
Albuterol